• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

INOSE Ryo  豕瀬 諒

ORCIDConnect your ORCID iD *help
… Alternative Names

Inose Ryo  豕瀬 諒

Less
Researcher Number 10868152
Other IDs
Affiliation (Current) 2025: 京都薬科大学, 薬学部, 助教
Affiliation (based on the past Project Information) *help 2025: 京都薬科大学, 薬学部, 助教
2021 – 2023: 京都薬科大学, 薬学部, 助教
2020: 京都薬科大学, 薬学部, 助手
Review Section/Research Field
Principal Investigator
Basic Section 58010:Medical management and medical sociology-related
Except Principal Investigator
Basic Section 47060:Clinical pharmacy-related / Basic Section 58010:Medical management and medical sociology-related
Keywords
Principal Investigator
リアルワールドデータ / 保険請求情報 / NDBオープンデータ / 販売量 / 嘔吐 / 悪心 / 支持療法 / 制吐薬 / レセプトデータ / 保険請求 … More / レセプト / 関節リウマチ / 悪性リンパ腫 / 悪性腫瘍 / 生物学的製剤 / メトトレキサート … More
Except Principal Investigator
薬剤耐性対策 / chronic heart failure / dapagliflozin / SGLT2 inhibitor / ビッグデータ / 大規模保険請求情報 / 医療ビッグデータ / 臨床疫学 / 薬剤疫学 / 保険請求情報 / リアルワールドデータ Less
  • Research Projects

    (5 results)
  • Research Products

    (7 results)
  • Co-Researchers

    (5 People)
  •  Exploring new indicators for combating antimicrobial-resistant using large-scale health insurance claim data

    • Principal Investigator
      村木 優一
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Kyoto Pharmaceutical University
  •  Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium–glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus

    • Principal Investigator
      栄田 敏之
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Kyoto Pharmaceutical University
  •  複数のリアルワールドデータを用いて制吐薬の適正使用に関する実態を評価できるのかPrincipal Investigator

    • Principal Investigator
      豕瀬 諒
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 58010:Medical management and medical sociology-related
    • Research Institution
      Kyoto Pharmaceutical University
  •  Verification of clinical usefulness obtained in basic and clinical research with real-world data

    • Principal Investigator
      Muraki Yuichi
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 58010:Medical management and medical sociology-related
    • Research Institution
      Kyoto Pharmaceutical University
  •  Clarification for risk of malignancy associated with treatment of rheumatoid arthritis based on large medical claims databasePrincipal Investigator

    • Principal Investigator
      Inose Ryo
    • Project Period (FY)
      2020 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 58010:Medical management and medical sociology-related
    • Research Institution
      Kyoto Pharmaceutical University

All 2023 2022

All Journal Article Presentation

  • [Journal Article] Risk of a second cancer and infection in patients with indolent B‐cell lymphoma exposed to first‐line bendamustine plus rituximab: A retrospective analysis of an administrative claims database2023

    • Author(s)
      Dote Satoshi、Inose Ryo、Goto Ryota、Kobayashi Yuka、Muraki Yuichi
    • Journal Title

      Hematological Oncology

      Volume: - Issue: 3 Pages: 354-362

    • DOI

      10.1002/hon.3128

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K10290
  • [Journal Article] Risks of malignant lymphoma in rheumatoid arthritis patients receiving methotrexate-alone and in combination therapy compared with the general population: A study based on a Japanese medical claims database2023

    • Author(s)
      Inose Ryo、Nakamura Arisa、Omi Rina、Takeno Shujiro、Muraki Yuichi
    • Journal Title

      Int. Journal of Clinical Pharmacology and Therapeutics

      Volume: 61 Issue: 10 Pages: 430-436

    • DOI

      10.5414/cp204372

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K18865
  • [Presentation] 生産年齢人口の関節リウマチ患者における悪性腫瘍の発現リスクの評価:大規模保険請求情報を用いた後方視的検討2023

    • Author(s)
      豕瀬諒、中村有沙、大見里奈、岳野秀二郎、村木優一
    • Organizer
      日本臨床腫瘍薬学会学術大会2023
    • Data Source
      KAKENHI-PROJECT-20K18865
  • [Presentation] 大規模保険請求情報を用いた生産年齢人口の関節リウマチ患者における悪性リンパ腫の発現状況の評価2023

    • Author(s)
      豕瀬諒、中村有沙、大見里奈、岳野秀二郎、村木優一
    • Organizer
      医療薬学フォーラム2023
    • Data Source
      KAKENHI-PROJECT-20K18865
  • [Presentation] ドセタキセルを投与された肺がん患者における呼吸器感染症の発現状況の評価: 基礎研究で得られた仮説に対する大規模保険請求情報を用いた検証2023

    • Author(s)
      豕瀬諒、後藤良太、細木誠之、芦原英司、村木優一
    • Organizer
      第143回日本薬学会
    • Data Source
      KAKENHI-PROJECT-21K10290
  • [Presentation] 有害事象自発報告データベースから得られた結果は大規模保険請求情報で検証できるのか?2022

    • Author(s)
      大見 里奈, 豕瀬 諒, 中村 有沙, 岳野 秀二郎, 村木 優一
    • Organizer
      日本臨床腫瘍薬学会学術大会2022
    • Data Source
      KAKENHI-PROJECT-20K18865
  • [Presentation] 大規模保険請求情報を用いた関節リウマチに対するメトトレキサート療法による悪性腫瘍と日本における悪性腫瘍の発現率の比較2022

    • Author(s)
      中村 有沙, 豕瀬 諒, 大見 里奈, 岳野 秀二郎, 村木 優一
    • Organizer
      日本臨床腫瘍薬学会学術大会2022
    • Data Source
      KAKENHI-PROJECT-20K18865
  • 1.  Muraki Yuichi (50571452)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 2 results
  • 2.  細木 誠之 (30433254)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 3.  栄田 敏之 (00304098)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  河渕 真治 (70747237)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  八尋 錦之助 (80345024)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi